文献
J-GLOBAL ID:201702238222031828
整理番号:17A1688917
EGFR変異肺癌でBIM欠失多型性と関係した耐性に対するボリノスタットおよびゲフィチニブを用いた併用治療の第I相試験(VICTROY-J):試験プロトコール
Phase I study of combined therapy with vorinostat and gefitinib to treat BIM deletion polymorphism-associated resistance in EGFR-mutant lung cancer (VICTROY-J): a study protocol
著者 (12件):
Takeuchi Shinji
(Division of Medical Oncology, Cancer Research Institute, Kanazawa University)
,
Yoshimura Kenichi
(Innovative Clinical Research Center (iCREK), Kanazawa University Hospital)
,
Fujiwara Tadami
(Center for Advanced Medicine and Clinical Research, Nagoya University Hospital)
,
Ando Masahiko
(Center for Advanced Medicine and Clinical Research, Nagoya University Hospital)
,
Shimizu Shinobu
(Center for Advanced Medicine and Clinical Research, Nagoya University Hospital)
,
Nagase Katsuhiko
(Innovative Clinical Research Center (iCREK), Kanazawa University Hospital)
,
Hasegawa Yoshinori
(Department of Respiratory Medicine, Nagoya University Graduate School of Medicine)
,
Takahashi Toshiaki
(Division of Thoracic Oncology, Shizuoka Cancer Center)
,
Katakami Nobuyuki
(Division of Integrated Oncology, Institute of Biomedical Research and Innovation)
,
Inoue Akira
(Department of Palliative Medicine, Tohoku University School of Medicine)
,
Yano Seiji
(Division of Medical Oncology, Cancer Research Institute, Kanazawa University)
,
Yano Seiji
(Innovative Clinical Research Center (iCREK), Kanazawa University Hospital)
資料名:
Journal of Medical Investigation (Web)
(Journal of Medical Investigation (Web))
巻:
64
号:
3.4
ページ:
321-325(J-STAGE)
発行年:
2017年
JST資料番号:
U0711A
ISSN:
1349-6867
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
日本 (JPN)
言語:
英語 (EN)